Some cancers are harder to diagnose than others¹. Differentiating between the various subtypes of lung cancer, even under a microscope, can be a very difficult task^2,3.

Until recently, no single test was available to help doctors accurately tell whether their patients had malignant pleural mesothelioma or another form of lung cancer⁴. miRview® meso is a unique kind of test. It uses cutting-edge technology to tell whether or not you have malignant pleural mesothelioma⁵.

Malignant pleural mesothelioma is a fast-moving disease⁶. If your doctor suspects you have it, it is important to get an accurate diagnosis as quickly as possible. This will help ensure that you start on the right treatment right away.

1. Yaziji H, Battifora H, Barry TS, et al. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol. 2006;19(4):514-523.
2. Marchevsky AM. Application of immunohistochemistry to the diagnosis of malignant mesothelioma. Arch Pathol Lab Med. 2008;132(3):397-401.
3. Stang A, Pohlabeln H, Müller KM, Jahn I, Giersiepen K, Jöckel KH. Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control study. Lung Cancer. 2006;52(1):29-36.
4. Klebe S, Mahar A, Henderson DW, Roggli VL. Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review. Mod Pathol. 2008;21(9):1084-1094.
5. Benjamin H, Lebanony D, Cohen L, et al. Differential diagnosis of mesothelioma using a microRNA assay. Presented at: 44th American Society of Clinical Oncology Annual Meeting; May 30-June 3, 2008; Chicago, IL. Abstract 22000.
6. Asbestosis mesothelioma information and resource guide. Accessed February 22, 2009.